Sargent Bickham Lagudis’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-165
| Closed | -$8K | – | 967 |
|
|
2021
Q3 | $8K | Hold |
165
| – | – | ﹤0.01% | 748 |
|
|
2021
Q2 | $13K | Hold |
165
| – | – | ﹤0.01% | 670 |
|
|
2021
Q1 | $9K | Hold |
165
| – | – | ﹤0.01% | 714 |
|
|
2020
Q4 | $14K | Hold |
165
| – | – | ﹤0.01% | 607 |
|
|
2020
Q3 | $6K | Sell |
165
-22
| -12% | -$800 | ﹤0.01% | 638 |
|
|
2020
Q2 | $5K | Buy |
+187
| New | +$5K | ﹤0.01% | 640 |
|